Publications found:
36,694
Sort by:
Warts (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Warts (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Warts - Drugs in Development, 2021, provides an over...
March 2021
117 pages
Ewing’s Sarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Ewing Sarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ewing Sarcoma development. The report provides ...
March 2021
60 pages
Vasculitis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Vasculitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vasculitis development. The report provides detailed ...
March 2021
60 pages
Blepharitis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Blepharitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Blepharitis development. The report provides detailed ...
March 2021
60 pages
Hepatic encephalopathy - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Hepatic Encephalopathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatic Encephalopathy development. The report provides ...
March 2021
60 pages
Hyperoxaluria - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Hyperoxaluria - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperoxaluria development. The report provides detailed ...
March 2021
120 pages
Lupus Nephritis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Lupus Nephritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Lupus Nephritis development. The report provides ...
March 2021
60 pages
Nasopharyngeal Cancer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Nasopharyngeal Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nasopharyngeal Cancer development. The report provides ...
March 2021
120 pages
Primary Biliary Cirrhosis - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Primary Biliary Cirrhosis The report also ...
March 2021
60 pages
Small Cell Lung Cancer - Pipeline Insight, 2021
US$ 3,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Small Cell Lung Cancer The report also ...
March 2021
240 pages
Wilson’s Disease - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Wilson Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Wilson Disease development. The report provides ...
March 2021
60 pages
Pheochromocytoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Pheochromocytoma - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline dru...
March 2021
60 pages
Adrenocortical Carcinoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Adrenocortical Carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...
March 2021
60 pages
Cystinuria - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Cystinuria - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in...
March 2021
60 pages
Endometrial Cancer - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Endometrial Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline d...
March 2021
60 pages
Gastroesophageal Reflux disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Gastroesophageal Reflux disease - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
March 2021
60 pages
Meniere’s Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Meniere’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
March 2021
60 pages
Ocular Hypertension - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Ocular Hypertension - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipelin...
March 2021
60 pages
Primary Open Angle Glaucoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Primary Open Angle Glaucoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...
March 2021
60 pages
Renal Cell Carcinoma - Pipeline Insight, 202
US$ 3,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Renal Cell Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeli...
March 2021
120 pages
CAR-T - Pipeline Insight, 2021
US$ 3,000.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “CAR-T – Pipeline Insight, 2021,” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in C...
March 2021
360 pages
Acute Liver Failure - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Acute Liver Failure – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...
March 2021
60 pages
Anal Cancer - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Anal Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in...
March 2021
60 pages
Hepatorenal syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Hepatorenal syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
March 2021
60 pages
Intraocular (Uveal) melanoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Intraocular (Uveal) melanoma – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15...
March 2021
120 pages
Waldenstrom’s macroglobulinaemia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Waldenstrom’s macroglobulinaemia – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies an...
March 2021
120 pages
Acute optic neuritis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Acute optic neuritis - Pipeline Insight, 2021,” report provides comprehensive insights about 2+ companies and 2+ pipeline...
March 2021
60 pages
Cerebral Infarction - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Cerebral Infarction – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipelin...
March 2021
120 pages
Mydriasis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Mydriasis – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in M...
March 2021
60 pages
Tuberous Sclerosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tuberous Sclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline d...
March 2021
60 pages
Global Osteoporosis Drugs Market, By Drug Class (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Parathyroid Hormone Therapy, Calcitonin, Rank Ligand Inhibitors, and Others), By Osteoporosis Disease Type (Primary Osteoporosis, Secondary Osteoporosis), By Route of Administration (Oral, Injectable, and Others), By Gender (Female, Male), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Forecast & Opportunities, 2026
US$ 4,500.00
The global osteoporosis drugs market stood at USD13.36 billion in 2020 and is projected to grow at a CAGR of 6.83% to cross USD20.17 billion by 2026. The increase in the prevalence of osteoporosis in...
March 2021
112 pages
